Clinical Relevance of Plasma Prostaglandin F2α Metabolite Concentrations in Patients with Idiopathic Pulmonary Fibrosis

An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management

(2011) Ganesh Raghu et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Risk Prediction in Idiopathic Pulmonary Fibrosis

(2011) Brett Ley et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Prostanoid Receptors

(2011) Takako Hirata et al.   CHEMICAL REVIEWS

Integrating mechanisms of pulmonary fibrosis

(2011) Thomas A. Wynn   JOURNAL OF EXPERIMENTAL MEDICINE

Idiopathic pulmonary fibrosis

(2011) Talmadge E King et al.   LANCET

Clinical Course and Prediction of Survival in Idiopathic Pulmonary Fibrosis

(2010) Brett Ley et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Pulmonary Hypertension and Idiopathic Pulmonary Fibrosis

(2010) Laszlo Farkas et al.   AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY

Basic Science of Pulmonary Arterial Hypertension for Clinicians

(2010) Stephen L. Archer et al.   CIRCULATION

Pulmonary function measures predict mortality differently in IPF versus combined pulmonary fibrosis and emphysema

(2010) S. L. Schmidt et al.   EUROPEAN RESPIRATORY JOURNAL

Incidence, Prevalence, and Clinical Course of Idiopathic Pulmonary Fibrosis

(2009) Evans R. Fernández Pérez et al.   CHEST

Prostaglandin F2α receptor signaling facilitates bleomycin-induced pulmonary fibrosis independently of transforming growth factor-β

(2009) Toru Oga et al.   NATURE MEDICINE

Eicosanoid Lipid Mediators in Fibrotic Lung Diseases

(2008) Steven K. Huang et al.   CHEST

Fleischner Society: Glossary of Terms for Thoracic Imaging

(2008) David M. Hansell et al.   RADIOLOGY